 |
02/18/2010 - Medline Industries to Sell BIOGUARD™ Wound Dressings with NIMBUS® Technology
Gainesville, Florida - February 18, 2010 - Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that its licensee, Derma Sciences, Inc. (NASDAQ: DSCI), has entered into an exclusive distribution agreement with Medline Industries whereby Medline will market and sell BIOGUARD™ wound dressings with Quick-Med's proprietary NIMBUS antimicrobial technology. The agreement covers the acute care segment of the health care market, which includes nearly 6,000 hospitals in the United States plus surgery centers, wound care centers, and other associated health care facilities. Sales under this new agreement are expected to start later this month.
|
 Read More... |
02/16/2010 - Quick-Med Technologies Expands NIMBUS® License for Derma Sciences' BIOGUARD™ Wound Dressings
Gainesville, Florida - February 16, 2010 - Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that it has amended its Patent and Technology License Agreement with Derma Sciences, Inc. (NASDAQ: DSCI) to grant Derma Sciences rights to use NIMBUS® technology in an expanded range of wound dressings formats marketed by Derma Sciences under its BIOGUARD™ trademark. The amendment also adjusts minimum royalties, provides terms for Derma Sciences entering into a private-label contract, and extends the term of the License for an additional three years subject to Derma Sciences meeting certain milestones and performance requirements. |
| Read More... |
01/29/2010 - Quick-Med’s Stay Fresh™ Technology Named as Textile World’s Quality Fabric of the Month
Gainesville, Florida – January 29, 2010 – Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that Textile World featured Quick-Med’s innovative Stay Fresh™ textiles technology as its Quality Fabric of the Month. |
| Read More... |
12/15/2009 - BIOGUARD™ Wound Dressings with NIMBUS®
Technology May Provide Safeguards
Against Influenza Viruses
Gainesville, Florida – December 15, 2009 – Quick-Med Technologies, Inc. (OTCBB:QMDT) announced today that its licensee, Derma Sciences, Inc. (OTCBB: DSCI), has reported that an independent laboratory has found that BIOGUARD™ barrier gauze dressings with Quick-Med’s novel NIMBUS antimicrobial technology exhibit high antiviral efficacy against the H1N1 virus. This new information increases the applicability of the dressings, which have already been shown to have high efficacy against virulent bacteria such as MRSA. |
| Read More... |
11/30/2009 - Quick-Med Technologies' CEO Talks With
The Wall Street Transcript
Gainesville, Florida - November 30, 2009 - Quick-Med Technologies, Inc. (OTCBB:
QMDT) announced today that The Wall Street Transcript (TWST) has included an
interview with the Company's CEO, J. Ladd Greeno, in the publication's latest
Pharmaceutical Report. |
View the Interview in PDF Format...
Read More... |
11/16/2009 - Quick-Med Technologies Receives First
Royalties for its NIMBUS® Wound Dressings
Gainesville, Florida – December 15, 2009 – Quick-Med Technologies, Inc. (OTCBB:QMDT) announced today that its licensee, Derma Sciences, Inc. (OTCBB: DSCI), has reported that an independent laboratory has found that BIOGUARD™ barrier gauze dressings with Quick-Med’s novel NIMBUS antimicrobial technology exhibit high antiviral efficacy against the H1N1 virus. This new information increases the applicability of the dressings, which have already been shown to have high efficacy against virulent bacteria such as MRSA. |
| Read More... |
10/23/2009 - FDA Issues Guidance for Quick-Med Technologies'
Exclusive Wound Dressing with pDADMAC
Gainesville, Florida - October 23, 2009 - Quick-Med Technologies, Inc. (OTCBB:
QMDT) announced today that the Food and Drug Administration has issued Guidance to
support the classification of the Company's NIMBUS® barrier gauze wound dressings as
Class II medical devices. This novel wound dressing received its initial market clearance
on February 25, 2009 via FDA's De Novo review process, a special clearance program
for medical devices that are found to be "not substantially equivalent" to any predicate
device. |
| Read More... |
10/14/2009 - USPTO and WIPO Publish NimbuDerm™
Patent Applications
Gainesville, Florida - October 14, 2009 - Quick-Med Technologies, Inc. (OTCBB:
QMDT), a pioneer in advanced antimicrobial technologies for medical and consumer
applications, announced today that the United States Patent and Trademark Office and
the World Intellectual Property Organization have published Company patent
applications covering Disinfectant Alcohol-Soluble Quaternary Ammonium Polymers. |
| Read More... |
| 10/02/2009 - Quick-Med Technologies to Present NIMBUS at Prestigious Clinical Symposium on Advances in Skin &Wound Care |
09/23/2009 - Quick-Med Technologies Announces the Development of Stay Fresh™ Textiles Technology
|
| 06/25/2009 - Quick-Med Technologies Announces First Commercial Sales of NIMBUS® Wound Care Products |
| 04/23/2009 - Quick-Med and Avery Dennison Enter Into Joint Development Agreement |
| 04/09/2009 - Quick-Med Technologies to Present NIMBUS at the Symposium on Advanced Wound Care and Wound Healing Society Meeting |
| 26/02/2009 - FDA Clears First Quick-Med Product |
| 18/11/2008 - New Study Reaffirms Quick-Med’s NIMBUS®
Technology Poses No Threat of Bacterial Resistance |
| 06/11/2008 - Quick-Med Technologies, Inc. Signs Manufacturing and Distribution Agreement with BASF Beauty Care Solutions |
| 05/21/2008 - NIMBUS®, NimbuDerm™ and MultiStat™ Technologies Selected for Presentation at Prestigious 3rd Congress of the World Union of Wound Healing Societies in Toronto |
| 05/15/2008 - Quick-Med’s Novel Wound Dressing Receives Recognition from the Wound Healing Society |
| 05/14/2008 - NimbuDerm™ Receives Wound Healing Society’s Blue Ribbon Award |
| 04/10/2008 - Quick-Med Technologies, Inc. Signs Joint Development
Agrement with a Leading Provider of
Health Care Products |
| 04/08/2008 - Quick-Med Technologies Presenting at Prestigious SAWC/WHS Conference |
03/11/2008 - Quick-Med Technologies is Developing a
Next Generation Skin Sanitizer Technology to Provide
Long-Lasting Protection from MRSA
|
| 02/12/2008 - Quick-Med Technologies' Research & Development Center Moves to New Location |
| 02/01/2008 - Dr. Olderman Highlights the Value of a Bonded Antimicrobial at Textiles Conference |
| 12/04/2007 - Dr. Olderman to Highlight Antimicrobial Protection in
Textiles Applications at Orlando Conference |
| 09/11/2007 - Quick-Med Technologies Appoints J. Ladd Greeno to Its Board of Directors |
| 08/09/2007 - Quick-Med Technologies Announces CEO Appointment |
| 08/02/2007 - Mexico grants Quick-Med Technologies, Inc. Notice of Allowance for its NIMBUS® Technology |
| 06/19/2007 - Quick-Med Technologies, Inc. and the University of Michigan Sign Patent Licensing Agreement |
| 04/24/2007 - Quick-Med Technologies, Inc. Awarded $1 Million Congressional Appropriation |
04/02/2007 - Quick-Med Technologies, Inc. Licenses NIMBUS Anti microbial
Technology To Derma Sciences, Inc. For Use In Wound Care Products
|
| 03/26/2007 - Quick-Med Technologies' Lead Molecule Ilomastat Selected for
Evaluation in Sulfur Mustard Gas Grant from NIH |
| 07/10/2006 - Quick-Med Technologies, Inc. Resolves Dispute With Cosmetics Distribution Partner |
| 26/07/2006 - Quick-Med Technologies, Inc. Competitively Selected By U.S. Army For a $770,000 Phase II SBIR Grant |
| 06/01/2006 - Quick-Med Technologies, Inc. to Address
Congressional 21st Century Health Care Caucus on Hospital Infection Prevention |
| 05/31/2006 - Quick-Med Technologies, Inc. Receives Wound Healing Society's Prestigious Blue Ribbon Award |
03/16/2006 - Quick-Med Technologies, Inc. Senior Scientist
Gregory S. Schultz Profiled in TIME Magazine
01/09/2006 - Cheryl L. Turnbull Elected to Board of Directors of Quick-Med Technologies, Inc.
12/08/2005 - Quick-Med Technologies, Inc. Receives Key Patent On Its NIMBUS™ Technology
U.S. Patent Allowance Significantly Strengthens Overall Patent Portfolio
11/15/2005 - Quick-Med Technologies, Inc. Awarded U.S. Army SBIR Phase I Contract
09/13/2005 - Quick-Med Technologies, Inc. and The University of Florida Collaborate to Develop The Next Generation of NIMBUS™ Anti microbial Technology
01/13/2005 - Quick-Med Technologies, Inc. Retains Elman Technology Law, P.C. |
| News Archive... |
 |
| |
